5 FU-GLS (Fluorouracil) 500MG 10ML 5’s

5-FU-GLS (Fluorouracil) 500mg/10ml is a widely used injectable chemotherapy medication designed for the palliative treatment of various solid tumors. It contains Fluorouracil, an antimetabolite that interferes with cancer cell growth and replication. This formulation is typically supplied in packs of 5 vials, each containing 500mg/10ml.

Fluorouracil is an essential component in cancer therapy protocols and is commonly used when surgery or other conventional methods are not appropriate. It is administered intravenously under strict clinical supervision, ensuring patient safety and proper dose adjustment based on medical evaluation.

This product is typically manufactured by GLS Pharma, known for producing oncology-grade pharmaceuticals.

This medication must be prescribed, handled, and administered only by trained healthcare professionals.

 Key Uses of 5-FU-GLS (Fluorouracil) 500mg/10ml

• Palliative treatment of colon and rectal cancer

• Management of breast cancer

• Treatment of stomach cancer

• Palliative care for pancreatic cancer

• Used when surgery or other standard treatments are not suitable

Administration & Dosage

• Route: Intravenous (IV) injection only

• Dosage: Determined by an oncologist based on:

  • Patient’s body weight

  • Type and severity of cancer

  • Blood counts (leukocytes and thrombocytes)

• Treatment may follow multi-day or cyclic regimens

• Must be administered in a medical facility with monitoring capability

Important Safety Considerations

• Prescription only

• Should be administered by qualified oncology professionals

• May cause significant toxicities, including:

  • Bone marrow suppression

  • Gastrointestinal side effects

  • Dermatological reactions

• Patients require close monitoring

• Uridine triacetate is used as an antidote in cases of overdose or severe toxicity